Europe Blister Packaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Europe Blister Packaging Market is Segmented By Process (Thermoforming​, Cold forming), Material (Plastic Films​, Paper, and Paperboard​, Aluminum​), End-User Industry (Consumer Goods​, Pharmaceutical, Industrial), and Country. ​

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2019
CAGR: 6.45 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Europe Blister Packaging Market is expected to reach a CAGR of 6.45% during the forecast period of 2020-2025. Growing pressure on pharmaceutical companies to manufacture medicines that are different in packaging and hard to imitate, surpassing the basic need of keeping it useful for the purpose it was produced, for it to be made available for patients, due to growth in diseases and stringent government regulations against counterfeit drugs, are among the significant factors propelling the market. Blister packaging provides an efficient method of anti-counterfeit systems, like banknote authentication systems and others.​

  • The UK pharmaceutical industry is one of the major players in research and innovation of the country. The industry contributes billions on R&D and employs vast numbers for highly-skilled R&D roles. According to the Association of the British Pharmaceutical Industry (ABPI), 23,000 people work in R&D out of 73,000 people employed directly by the pharmaceutical industry. These vast investments and the proportion of skilled workers employed, projects light on how the UK is building up the pipeline of medicines and future drugs. This can be seen as a good opportunity for the growth of blister packaging in the region. The growing older population in the country is also seen as a major driver for the market's growth over the forecast period.​
  • The use of innovative technologies in blisters, such as RFID (radio frequency identification tags), deployed with a seal applied outside the packaging, is increasing due to the potential to offer individual security throughout supply chains. Contamination of samples in blisters only occurs when the protective barrier is broken, when a single capsule or tablet is dispensed or administered.​
  • Furthermore, the outbreak has increased the research across the world for developing a vaccine for COVID-19. For instance, the healthcare giant, Johnson & Johnson, decided to to start clinical trials in September 2020 and has received a nearly USD 500 million partnership via a division of the US Department of Health and Human Services. ​​
  • Also, experimental vaccines developed by researchers at the University of Pittsburgh and Baylor College of Medicine in Houston are also waiting for permission from the Food and Drug Administration to begin testing in people. The success of these vaccines developed by the researchers might follow the large-scale manufacture of them, further driving the demand for liquid bottles.​​​

Scope of the report

Blister pack is a term for several types of pre-formed plastic packaging used for foods, pharmaceuticals, and small consumer goods. These packaging solutions are beneficial for protecting products against external factors, such as contamination and humidity, for extended periods. Opaque blisters also protect light-sensitive products against UV rays. Such a broad base of application has helped it gain traction in the market. The provides a detailed analysis of various processes used for blister packaging along with the different types of material and an analysis of the end-user industries using such type of packaging.

By Process
By Material
Plastic Films
Paper and Paperboard
Other Materials
By End-User Industry
Consumer Goods
Other End-user Industries
By Country
CIS countries
Rest of Europe

Report scope can be customized per your requirements. Click here.

Key Market Trends

Pharmaceutical is Expected to Witness a Significant Growth

  • The pharmaceutical sector poses a different set of demands for the blister packaging solutions, concerning insulation from external surroundings, cost-effectiveness, high levels of protection, and the ease of handling and retaining the effectiveness of the medicine.​These packs are uniquely suited to meet the stringent regulations and are highly valued for protective properties, cost-effectiveness, adaptability, and the pharmaceutical and packaging industry's requirements.​
  • When medicines are blister packaged, adherence is improved because consumers can keep track of their medications and dosage. The unit dosage feature of blisters reduces the risk of incorrect dosing.​
  • The retail-level preparation of prescription drugs is troubling pharmaceutical technicians or pharmacists. The administration of medicines in the open atmosphere of the supermarket and drug store may negatively affect sensitive medicines when they are transferred from container to container. Blister packaging can guarantee the process of distribution directly to the customer.​
  • Protecting product integrity continues to be the primary goal of pharmaceutical packaging, but there is continued work on cost reduction in the packaging process in all areas of the packaging industry. ​For instance, The Polybar barrier films product families provided by Amcor cover a wide range of moisture barriers, whilst also providing good crush resistance to ensure the best protection for pharmaceutical applications such as tablets and capsules. It uses material such as Aclar, COC, PE, PVC, and PVdc, among others. ​
  • Further, the outbreak of the COVID-19 has increased the market for blister packaging. In October 2019, the Ukrainian pharmaceutical company Darnitsa passed the state registration for an experimental drug in the treatment protocol for COVID-19. A few countries across the region have banned the export of medicines that have shown efficacy in the fight against coronavirus infection, and first and foremost, meet the domestic demand. The Darnitsa pharmaceutical company passed the state registration for hydroxychloroquine substance – an experimental drug that is included in the treatment protocol for COVID-19.​
europe blister graph1.png

CIS Countries are Expected to WItness SIgnificant Growth

  • Among the CIS countries, Russia is anticipated to hold a significant share. The pharmaceutical industry in Russia, one of the Commonwealth of Independent States (CIS) countries, can be considered one of the most complex sectors when considering the management of the intellectual property (IP), as it involves complicated legal, regulatory, linguistic, and marketing factors.​
  • The country has been witnessing significant growth in drug production. According to the Russian Ministry of Industry and Trade, the Russian government expects a 20% growth of domestic drug production in 2020, which is responsible for developing the pharmaceutical industry in the Russian government. ​
  • According to the Minister, the expected growth will be comparable to that which was observed in the first four months of 2020 and was mainly due to the commissioning of some new production facilities within the country. ​
  • However, the Russian government has also prepared a new startegy – the state program Pharma 2030, which should get the pharmaceutical sector's positive trends. The past decade's results, the expectations for the new program, and the promising areas and locations for investments in pharmaceuticals are mentioned in the material of the Moscow Region Development Corporation (MRDC). ​
  • And according to MRDC, in the near future, Russia will start implementing the state strategy of pharmaceutical industry development Pharma 2030. The strategy indicates the main industry directions, the growth of which will be stimulated with the help of the state support mechanisms. The previous state program of the country Pharma 2020 gave a strong impetus for developing the medical and pharmaceutical sectors, particularly at the initial stage of implementation. Industry players can expect a good start from the new state program, which is anticipated to augment the market growth in CIS region.​
europe blister graph 2.png

Competitive Landscape

The market for Europe Blister Packaging Market is moderately fragmented. Partnership, mergers, and acquisitions have been a significant strategy for the vendors in the market for producing products that are acceptable in the end-user industry, where packaging materials undergo stringent quality tests to not contaminate the contents impact health. Maintaining a continuous flow of raw materials remain a challenge that prompts partnerships.

  • February 2020 - Consumer packaging company Sonoco’s Alloyd business launched an all-paper retail blister package. Named EnviroSense PaperBlister, the new packaging is an alternative to the existing thermoformed plastic blister package. Designed to be environmentally friendly, EnviroSense PaperBlister is a plastic-free package and is recyclable in the paper stream. The packaging is also available with the Sustainable Forestry Initiative (SFI) Certification.
  • January 2020 - Amcor partnered with Moda to offer innovative packaging solutions. Amcor and Moda offer multiple innovative solutions in flexible packaging and are expected to offer new resources to help gain and further strengthen Amcor’s position in the flexible packaging market.​

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing geriatric population and prevalence of diseases

      2. 4.2.2 Product innovations such as downsizing coupled with relatively low costs

    3. 4.3 Market Challenges

      1. 4.3.1 Dynamic nature of regulations and inability to support heavy goods

    4. 4.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Intensity of Competitive Rivalry

      5. 4.4.5 Threat of Substitutes

    5. 4.5 Assessment of the impact of COVID-19 on Blister Packaging Market


    1. 5.1 By Process

      1. 5.1.1 Thermoforming

      2. 5.1.2 Coldforming

    2. 5.2 By Material

      1. 5.2.1 Plastic Films

      2. 5.2.2 Paper and Paperboard

      3. 5.2.3 Aluminum

      4. 5.2.4 Other Materials

    3. 5.3 By End-User Industry

      1. 5.3.1 Consumer Goods

      2. 5.3.2 Pharmaceutical

      3. 5.3.3 Industrial

      4. 5.3.4 Other End-user Industries

    4. 5.4 By Country

      1. 5.4.1 CIS countries

      2. 5.4.2 UK

      3. 5.4.3 Germany

      4. 5.4.4 France

      5. 5.4.5 Rest of Europe


    1. 6.1 Company Profiles

      1. 6.1.1 Amcor PLC

      2. 6.1.2 Westrock Company

      3. 6.1.3 Constantia Flexibles GmbH

      4. 6.1.4 Sonoco Products Company

      5. 6.1.5 Klockner Pentaplast Group

      6. 6.1.6 E.I. Du Pont De Nemours and Company

      7. 6.1.7 Honeywell International Inc.

      8. 6.1.8 The Dow Chemical Company

      9. 6.1.9 Tekni-Plex Inc.

    2. *List Not Exhaustive


**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Europe Blister Packaging Market market is studied from 2018 - 2026.

The Europe Blister Packaging Market is growing at a CAGR of 6.45% over the next 5 years.

Amcor PLC​, Westrock Company​, Sonoco Products Company​, Constantia Flexibles GmbH​, Honeywell International Inc. are the major companies operating in Europe Blister Packaging Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!